Jump to content

wooshka

Members
  • Posts

    107
  • Joined

  • Last visited

  • Days Won

    7

Posts posted by wooshka

  1. As you all know, there hasn't always been a certain link between HPPD and the genetic predisposition it may impose. 

    I have some interesting facts to share with you, as you know, I have HPPD, but.. so does my brother. 

    Another interesting fact is that my mother has suffered from Migraines basically since I can remember, now if this isn't something to do with genetics involving Migraines and or a predisposition, it's one hell of a coincidence. 

    Please share your thoughts and I'll try and answer any question you have. 

    • Upvote 14
  2. Hey guys, I'm fairly active on this site even if I don't post much, I'm always browsing and always willing to have a conversation with you.
    If you guys want to have a discussion about anything, if you're feeling like shit on a particular day or just need some reassurance or company that someone is going through this also, you can MSG me here, and I will reply mostly daily, or:

    www.facebook.com/rawrdy

    Hit me up for a chat if you need too. 
    Hope this helps some of you.

    -wooshy

    • Upvote 5
  3. Thank you for the reply Blunder, I'm just curious as to why it would seem that they're just progressing on their own, but I do understand what you mean in regards to the noticing of symptoms depending on your environmental factors. I'm not even into my first year with this stuff yet, so I'm feeling quite alot of zemblanity as to whats next. I will try magnesium as it has seemed to given most people a positive outcome. Thanks again. 

  4. "Atypical antipsychotic drugs (AAPDs) have been suggested to be more effective in improving cognitive impairment in schizophrenia than typical APDs, a conclusion supported by differences in receptor affinities and neurotransmitter efflux in the cortex and the hippocampus. More potent serotonin (5-HT)2A than dopamine (DA) D2 receptors antagonism, and direct or indirect 5-HT1A agonism, characterize almost all AAPDs. Blonanserin, an AAPD, has slightly greater affinity for D2 than 5-HT2A receptors. Using microdialysis and UPLC-MS/MS, we compared the abilities of the typical APD, haloperidol, three AAPDs, blonanserin, lurasidone, and olanzapine, and a selective 5-HT1A partial agonist, tandospirone, and all, except haloperidol, were found to ameliorate the cognitive deficits produced by the N-methyl-d-aspartate antagonist, phencyclidine, altering the efflux of neurotransmitters and metabolites in the rat cortex and nucleus accumbens. Blonanserin, lurasidone, olanzapine and tandospirone, but not haloperidol, increased the efflux of cortical DA and its metabolites, HVA and DOPAC. Olanzapine and lurasidone increased the efflux of acetylcholine; lurasidone increased glutamate as well. None of the compounds significantly altered the efflux of 5-HT or its metabolite, 5-HIAA, or GABA, serine, and glycine. The ability to increase cortical DA efflux was the only shared effect of the compounds which ameliorates the deficit in cognition in rodents following phencyclidine."

  5. "Atypical antipsychotic drugs (AAPDs) have been suggested to be more effective in improving cognitive impairment in schizophrenia than typical APDs, a conclusion supported by differences in receptor affinities and neurotransmitter efflux in the cortex and the hippocampus. More potent serotonin (5-HT)2A than dopamine (DA) D2 receptors antagonism, and direct or indirect 5-HT1A agonism, characterize almost all AAPDs. Blonanserin, an AAPD, has slightly greater affinity for D2 than 5-HT2A receptors. Using microdialysis and UPLC-MS/MS, we compared the abilities of the typical APD, haloperidol, three AAPDs, blonanserin, lurasidone, and olanzapine, and a selective 5-HT1A partial agonist, tandospirone, and all, except haloperidol, were found to ameliorate the cognitive deficits produced by the N-methyl-d-aspartate antagonist, phencyclidine, altering the efflux of neurotransmitters and metabolites in the rat cortex and nucleus accumbens. Blonanserin, lurasidone, olanzapine and tandospirone, but not haloperidol, increased the efflux of cortical DA and its metabolites, HVA and DOPAC. Olanzapine and lurasidone increased the efflux of acetylcholine; lurasidone increased glutamate as well. None of the compounds significantly altered the efflux of 5-HT or its metabolite, 5-HIAA, or GABA, serine, and glycine. The ability to increase cortical DA efflux was the only shared effect of the compounds which ameliorates the deficit in cognition in rodents following phencyclidine."

    Would these purpose any benefit to us? I've ever seen anyone on the forum discuss them before. Maybe some of you more well experienced users will have something to say in regards to this. 

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.